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Strategies to improve function after CNS injuries must contend with the failure of axons to regrow after tran-
section in adult mammals. In this issue of Neuron, Smith et al. provide an important advance by demon-
strating that SOCS3 acts as a key negative regulator of adult optic nerve regeneration.A fundamental characteristic of the
mature mammalian CNS is the failure of
neurons to accomplish long-range axonal
regeneration after injury. Regeneration
failure is explained in part by the presence
of numerous molecules that act as bar-
riers for central axon growth (Benowitz
and Yin, 2008). The recent identification
of a receptor for chondroitin sulfate
proteoglycans, known inhibitors of axon
regeneration, provides an outstanding
example of the ongoing progress in
understanding inhibitory mechanisms
(Shen et al., 2009). Nevertheless, blocking
negative extracellular influences alone
appears to be insufficient to enable exten-
sive axon elongation after CNS injury.
In striking contrast to PNS neurons,
CNS neurons undergo a permanent
downregulation of axon growth potential
during development (Goldberg et al.,
2002). Exciting recent work has defined
some of the mechanisms underlying this
reduced intrinsic growth potential (Moore
et al., 2009). Particularly important is the
demonstration that adult CNS neurons
possess a diminished capacity to activate
the mTOR-regulated protein synthesis
machinery after injury (Park et al., 2008).
Elimination of phosphatase and tensin
homolog (PTEN) activates mTOR and
allows some CNS neurons to regenerate
axons. In this edition of Neuron, Smith
et al. report that suppressor of cytokine
signaling 3 (SOCS3) is another critical
negative regulator of CNS regeneration
(Smith et al., 2009).
The SOCS family of proteins is com-
prised of eight family members that func-
tion as intracellular inhibitors of cytokine
signaling. SOCS proteins primarily inhibit
JAK-STAT signaling through binding to
JAK and/or specific phospho-tyrosineresidues on cytokine receptors. Many
physiological functions are regulated
by SOCS proteins, including inflamma-
tory, immune, endocrine, and oncogenic
responses (Croker et al., 2008). SOCS1,
-2, and -3 are perhaps the best character-
ized of the family, and each is expressed
in the nervous system (Miao et al., 2006;
Park et al., 2009). Injury-induced cytokine
signaling is critical for triggering adult
regenerative responses, especially the
successful regrowth that occurs in the
PNS. In the CNS, lens injury activates
cytokines and other processes that
improve the regeneration of retinal gan-
glion cells (RGCs) after nerve crush and
is akin to the conditioning lesion effect in
the PNS (Leon et al., 2000; Leibinger
et al., 2009). It is perhaps surprising then
that little is known about the role of
SOCS family members in regeneration.
A major impediment to CNS regenera-
tion studies has been the technical diffi-
culty of the assays employed. Spinal
cord injury has been the most commonly
utilized paradigm, but this model can be
difficult to standardize. Tracing regenerat-
ing axons over many spinal cord seg-
ments is complex, and axon elongation
can be difficult to distinguish from com-
pensatory sprouting. Lesioning the optic
nerve has become a favored model since
these issues are more easily controlled.
After a careful and full optic nerve crush
in control animals, virtually no axons
regenerate. Further, the favorable geom-
etry of the model allows for a straight-
forward and quantitative assessment of
strategies that promote regeneration.
Park et al. demonstrated the power of
thismodel in floxed allelemice using intra-
vitreal injections of adenoviruses encod-
ing Cre (AAV-Cre), which infect greaterNeuron 64, Dthan 90% of RGCs (Park et al., 2008). In
theory, the influence of almost any
intracellular signaling molecule that
suppresses the growth of mature RGC
neurons can be assessed in this manner.
Here, the authors tested the role of
SOCS3 by injecting AAV-Cre into the
eye of SOCS3fl/fl mice. The optic nerve
was crushed, and RGC regrowth and
survival were evaluated. Strikingly, RGC
axons regenerated up to 1.5 mm, and
survival was significantly increased.
Much of the regrowth occurred 3–7 days
postinjury and was correlated with an
increased level of phospho-S6 labeling,
an indicator of mTOR activity. The extent
of axon elongation following SOCS
deletion was, however, less than that
observed in PTEN-deleted mice (3 mm),
raising the possibility that additional
growth-suppressing pathways may con-
verge on mTOR (Park et al., 2008).
The authors next reasoned that endog-
enous SOCS3 functions to dampen the
response to injury-induced cytokines
that act through gp130. Coexpression of
gp130 and SOCS3 transcripts in adult
RGCs was demonstrated. Further, injec-
tion of AAV-Cre into SOCS3fl/fl gp130fl/fl
double-mutant retina failed to induce
significant regrowth after optic nerve
crush. Presumably, SOCS3 is reducing
the intrinsic growth potential of central
neurons by inhibiting the efficacy of
JAK-STAT signaling, although STAT
activation was not rigorously assessed.
These experiments suggest that RGC
regrowth following SOCS3 deletion is
dependent upon signaling through a
gp130-dependent cytokine signaling
cascade.
To explore the identity of injury-induced
signals linked to gp130, the expression ofecember 10, 2009 ª2009 Elsevier Inc. 591
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the three cytokines studied, only CNTF
was found to show increased expression
in the ganglion cell layer, which peaked
6 hr postinjury. These data suggest that
CNTF may mediate an injury-induced
response via gp130. Important in this re-
gard are the recent results of Leibinger
et al., which show that the effect of lens
injury on RGC regeneration is reduced in
CNTF/ mice and totally blocked in
CNTF/ LIF/ double-mutant mice (Lei-
binger et al., 2009). Together these results
suggest that CNTF and LIF are function-
ally relevant injury-induced factors.
Having shown that SOCS3 blocks
endogenous injury-induced signaling, the
authors asked if regeneration in response
to exogenously applied cytokines can be
enhanced by deleting SOCS3. Consistent
with previous reports, the injection of
exogenous CNTF induced modest regen-
eration after nerve injury. Importantly, the
combination of exogenous CNTF and
SOCS3 deletion resulted in nearly a
2-fold increase in the number and length
(2.5 mm) of axons projecting past the
crush site when compared to SOCS3
deletion alone. Many previous attempts
at augmenting CNS regrowth with exoge-
nous CNTF or other trophic factors have
met with limited success. It is interesting
to consider the possibility that SOCS3
(and other negative regulators) may have
been acting as constitutive brakes, frus-
trating these prior efforts.
The findings of Smith et al. highlight the
critical role of cytokine signaling in the
successful regeneration of central axons.
As the authors point out, simply activating
the mTOR pathway is not enough to
elicit growth in the absence of an injury-
induced signal. It is clear that SOCS3
represents an outstanding target for592 Neuron 64, December 10, 2009 ª2009 Efurther enhancing the effects of cytokines.
Identification of the transcriptional targets
of cytokine signaling will be an important
focus for future research.
Much remains to be learned about the
interactions among the intracellular path-
ways that have been associated with
successful regeneration. For example,
the growth-promoting effects of cyclic
AMP appear to be mediated in part by
downregulation of SOCS3 (Park et al.,
2009). On the other hand, another regen-
eration-promoting factor, oncomodulin,
promotes RGC regrowth in a JAK/STAT-
independent manner (Yin et al., 2006).
Regeneration-induced signals acting
through receptor tyrosine kinases and
activating the MAPK pathway (Lorber
et al., 2009) may be similarly independent
of SOCS3. Importantly, as the authors
have shown, loss of SOCS3 restores acti-
vation of the protein synthesis machinery,
which is presumably required for the
effects of all growth-enhancing signals.
Are the current approaches being
developed in rodent models capable of
triggering clinically relevant responses in
the human CNS? Importantly, few of
these interventions have been tested in
a primate model where the anatomy and
distances of axon growth that must be
achieved would better approximate the
situation in humans. Further, the com-
plexity of human injuries that are associ-
ated with large scars and cavity formation
in the spinal cord are not really addressed
in these optic nerve models. Leaving the
enormous translational obstacles aside,
there appears to be reason for cautious
optimism over the long term. Combinato-
rial therapies show progressive enhance-
ments of axon regrowth in rodent models.
Additionally, appropriate combinatorial
therapies can result in functional improve-lsevier Inc.ment even after long-standing injury (Ka-
doya et al., 2009). Smith et al. provide
compelling data suggesting that SOCS3
silencing may add to the beneficial effects
of current therapeutic approaches.
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